Gordon Guyatt
Physician and pioneer of evidence-based medicine
Gordon Guyatt coined the term "evidence-based medicine" at McMaster University in 1991 — the same framework that now underpins how Swedish, Finnish, Dutch and EU health bodies evaluate paediatric gender interventions. His Beyond Gender appearance laid bare a striking contradiction: the architect of rigorous clinical appraisal admits he signed a statement endorsing gender-affirming care without reading it.
Gordon Guyatt is a Distinguished University Professor at McMaster University in Canada. In 1991 he coined the term "evidence-based medicine" — a phrase that has since become the operating framework for clinical guideline-making from Stockholm to Brussels. European health authorities routinely invoke EBM principles when assessing the strength of evidence behind medical protocols, including those for paediatric gender care.
His systematic reviews of the evidence for gender-affirming medical interventions returned a verdict of low quality — the same conclusion that led Sweden, Finland and the United Kingdom to restrict those interventions for minors. That convergence carries particular weight: the methodological standards he helped establish are precisely the tools the Swedish and Finnish authorities applied when they paused puberty blockers and cross-sex hormones for minors, and the framework that informed the Cass Review in the UK.
In the episode Gordon Guyatt's Confession: What the Father of Evidence-Based Medicine Didn't Read (Beyond Gender, #36, 8 September 2025), hosts Stella O'Malley, Mia Hughes and Dr Bret Alderman drew out a striking admission: Guyatt signed a public statement endorsing gender-affirming care without having read it. For European audiences the disclosure is significant. Statements of professional consensus — often originating in North America and adopted by clinicians and policymakers across the continent — have helped shape clinical practice in countries that have not yet conducted their own systematic reviews.
The confession does not come from an adversary of gender medicine but from the man who built the very instrument used to evaluate it. That makes his testimony both more credible and more unsettling for health systems that have relied on the authority of such declarations rather than the evidence behind them.
